ModelEdge

Arena Pharmaceuticals Inc
0001080709
Filing TypeS-8
Filing Date6/18/2020
Updated6/19/20, 11:28 AM

Filing

S-8
Earnings Release

Exhibits

S-8Registration Statement for Securities to be Offered to Employees
EX-5.1OPINION OF COOLEY LLP
EX-23.1CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-99.1ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN
EX-99.2ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN
EX-99.3FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS UNDER THE ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN
EX-99.4FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN
EX-99.5FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER THE ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN
EX-99.6FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER THE ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN
GRAPHICGraphic